Idorsia Ltd (IDIA.SW)
CHF 1.3
(2.45%)
CHF 1.3
(2.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 931 Million CHF | -23.59% |
| 2022 | 1.21 Billion CHF | 5.66% |
| 2021 | 1.15 Billion CHF | 82.91% |
| 2020 | 630.46 Million CHF | 1.27% |
| 2019 | 622.58 Million CHF | 9.06% |
| 2018 | 570.84 Million CHF | 56.53% |
| 2017 | 364.68 Million CHF | 24.29% |
| 2016 | 293.42 Million CHF | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 931.39 Million CHF | 0.02% |
| 2024 Q1 | 931.19 Million CHF | 0.02% |
| 2024 Q3 | 785.83 Million CHF | 0.02% |
| 2023 Q3 | 999.3 Million CHF | -16.79% |
| 2023 Q4 | 931 Million CHF | -6.84% |
| 2023 FY | 931 Million CHF | -23.59% |
| 2023 Q1 | 1.21 Billion CHF | -0.2% |
| 2023 Q2 | 1.2 Billion CHF | -1.24% |
| 2022 Q2 | 1.19 Billion CHF | 0.34% |
| 2022 Q4 | 1.21 Billion CHF | 2.53% |
| 2022 FY | 1.21 Billion CHF | 5.66% |
| 2022 Q1 | 1.18 Billion CHF | 3.0% |
| 2022 Q3 | 1.18 Billion CHF | -0.29% |
| 2021 Q1 | 630.22 Million CHF | -0.04% |
| 2021 FY | 1.15 Billion CHF | 82.91% |
| 2021 Q4 | 1.15 Billion CHF | -7.34% |
| 2021 Q3 | 1.24 Billion CHF | 97.53% |
| 2021 Q2 | 630.02 Million CHF | -0.03% |
| 2020 FY | 630.46 Million CHF | 1.27% |
| 2020 Q1 | 625.58 Million CHF | 0.48% |
| 2020 Q2 | 626.11 Million CHF | 0.08% |
| 2020 Q3 | 627.03 Million CHF | 0.15% |
| 2020 Q4 | 630.46 Million CHF | 0.55% |
| 2019 Q2 | 630.37 Million CHF | 1.03% |
| 2019 FY | 622.58 Million CHF | 9.06% |
| 2019 Q4 | 622.58 Million CHF | -1.42% |
| 2019 Q1 | 623.92 Million CHF | 9.3% |
| 2019 Q3 | 631.53 Million CHF | 0.18% |
| 2018 Q1 | 366.57 Million CHF | 0.52% |
| 2018 FY | 570.84 Million CHF | 56.53% |
| 2018 Q3 | 568.81 Million CHF | 54.36% |
| 2018 Q2 | 368.48 Million CHF | 0.52% |
| 2018 Q4 | 570.84 Million CHF | 0.36% |
| 2017 Q1 | 296.88 Million CHF | 0.0% |
| 2017 FY | 364.68 Million CHF | 24.29% |
| 2017 Q4 | 364.68 Million CHF | 0.53% |
| 2017 Q3 | 362.76 Million CHF | 0.5% |
| 2017 Q2 | 360.95 Million CHF | 21.58% |
| 2016 FY | 293.42 Million CHF | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Addex Therapeutics Ltd | 70.38 Thousand CHF | -1322723.245% |
| BB Biotech AG | 304.9 Million CHF | -205.347% |
| Basilea Pharmaceutica AG | 95.45 Million CHF | -875.332% |
| Evolva Holding SA | - CHF | -Infinity% |
| Kuros Biosciences AG | 1.56 Million CHF | -59389.01% |
| Molecular Partners AG | 2.44 Million CHF | -37993.412% |
| Relief Therapeutics Holding AG | 9000.00 CHF | -10344377.778% |
| Santhera Pharmaceuticals Holding AG | 1.47 Million CHF | -62890.731% |